It was said that it should never be done and it was malicious because it was deliberate. This is a concern from the National Assembly, the government, and the pharmaceutical industry looking at the situation of BINEX, which violated the pharmaceutical affairs law due to suspicion of manufacturing method and dosage manipulation, which is also a bad thing for the global prestige of domestic drugs.

The confidence in the quality of domestic drugs, which only recovered after the detection of NDMA, a suspected carcinogen, has been broken again. In this case, the violation of the Pharmaceutical Affairs Law, such as the intentional manipulation of the manufacturing method of a specific pharmaceutical company,